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Abstract
The human microbiome refers to the community of microorganisms including prokaryotes, viruses
and microbial eukaryotes that populate the human body. The National Institutes of Health launched
an initiative that focuses describing the diversity of microbial species associated with health and
disease. The first phase of this initiative includes the sequencing of hundreds of microbial reference
genomes, coupled to metagenomic sequencing from multiple body sites. Here we present results
from an initial reference genome sequencing of 178 microbial genomes. From 547,968 predicted
polypeptides that correspond to the gene complement of these strains “novel” polypeptides that had
both unmasked sequence length > 100 amino acids and no BLASTP match to any non-reference
entry in the nr subset were defined. This analysis resulted in a set of 30,867 polypeptides, of which
29,987 (~97%) were unique. In addition, this set of microbial genomes allows for ~ 40% of random
sequences from the microbiome of the gastrointestinal tract to be associated with organisms based
on the match criteria used. Insights into pan-genome analysis suggest that we are still far from
saturating microbial species genetic datasets. In addition, the associated metrics and standards used
by the group for quality assurance are presented.
The human microbiome is the enormous community of microorganisms occupying the habitats
of the human body. Different microbial communities are found in each of the varied
environments of human anatomy. The aggregate microbial gene tally surpasses that of the
human genome by orders of magnitude. The relationship of the microbial content to health and
disease is one of the primary goals of human microbiome studies. The structure and function
of any microbial community requires a detailed definition of the genomes that it encompasses
and predicting and annotating their genes.
In 2007, the National Institutes of Health (NIH) initiated the Human Microbiome Project
(HMP) as one of its Roadmap initiatives (1) to provide resources and build the research
infrastructure. One component of the HMP is production of reference genome sequences for
at least 900 bacteria from the human microbiome to catalog the microbial genome sequences
from the human body and aid researchers conducting human metagenomic sequencing to assign
species to sequences in their metagenomic data sets.
The HMP catalog of reference sequences is being produced by the NIH HMP Jumpstart
Consortium of four Genome Centers: the Baylor College of Medicine Human Genome
Sequencing Center; the Broad Institute; the J. Craig Venter Institute; and the Genome Center
at Washington University. The challenges for the Jumpstart Consortium include selecting
strains to sequence and identifying sources, creating standards for sequencing and annotation
to ensure consistency and quality, and rapid release of information to the community.
Reference genome progress
To date, 239 genomes including 61 genomes at various stages of upgrading have been produced
by the Jumpstart Consortium and released into public databases. At the time of manuscript
preparation, 178 had been completely annotated and are presented in the analysis here. The
process for selection of these strains is described in the supporting online material. The strains
sequenced to date are distributed among body sites as follows: gastrointestinal tract (151), oral
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cavity (28), urogenital/vaginal tract (33), skin (18), respiratory tract (8), and also include one
isolate from blood (see (2)). These are the five major body sites targeted by the HMP.
The broad phylogenetic distribution of the sequenced strains (Figure 1) represents a 16S rRNA
overlay of HMP sequenced genomes on 16S rRNA sequences from cultured organisms with
sequenced genomes (3). HMP-sequenced genomes represent two kingdoms (Bacteria and
Archaea), 9 phyla, 18 classes, and 24 orders. Additional rRNA overlay figures broken down
by individual body sites are available (4).
To obtain high quality draft genomes and a meaningful gene list, minimum standards were
defined for assembly and annotation of draft genomes. Three reference bacterial genome
assemblies were evaluated for efficacy of gene predictions and genome completeness. Based
on the analysis, metrics for assembly characteristics and annotation characteristics were
defined (for more details see supporting online materials). The quality of HMP genome
assemblies are summarized in Table 1 and exceed the Jumpstart Consortium standards
described in the supporting online materials with the exception of some genomes produced
before standards were in place. More stringent metrics (N75 and N90 for contig and scaffold
continuity) are presented, and nearly all genomes satisfy these higher standards.
Genome improvement
As described in supporting online materials, there are justifications for upgrading these High
Quality Draft assemblies. The Jumpstart Consortium has completed initial improvement work
on 26 bacterial genomes that differed significantly with respect to GC content and assembly
metrics to explore the effort required and resulting benefits (Figure 2). The average contig N50
increased 3.63-fold, from 109 kb at draft to 396 kb after improvement. Bacteroides
pectinophilus displays substantial improvement in N50, from 163 kb in the draft sequence to
862 kb after improvement. Lactobacillus reuteri illustrates the opposite extreme with
improvement leading to a smaller contig N50 change, 56 kb to 72 kb. As more genomes
improve and some graduate to higher levels of improvement, the assembly state or group of
states most useful to the HMP scientific goals will be evaluated.
Pan-genome analysis
A bacterial species’ pan-genome can be described as the sum of the core genes shared among
all sequenced members of the species, and the dispensable genes, or those genes unique to one
or more strains studied. To start addressing questions about pan-genomes, we identified all
species within our sequenced reference genome catalogue for which there was more than one
sequenced and annotated genome. Of the nine species identified, four have five or more
annotated genomes, generated either by the HMP or external projects publicly available at
NCBI; five genomes being the minimum number for which a curve can reliably be fit to pan-
genome data. These are Lactobacillus reuteri, Bifidobacterium longum, Enterococcus
faecalis and Staphylococcus aureus. The genomic data used for the analysis consisted of both
complete and draft genomes, the only requirement being that >90% of the genome is
represented in the available annotated contigs or scaffolds.
Pan-genome curves (5) of the GIT isolates L. reuteri, B. longum, and E. faecalis (Figures S3-5)
are consistent with an open pan-genome model, suggesting that more genome sequencing needs
to be undertaken in order to characterize the actual make up of the species as a whole.
Preliminary results suggest core genome sizes of approximately 1430 genes, 1800 genes and
1600 genes for B. longum, E. faecalis and L. reuteri, respectively. Based on the current core
gene plots, L. reuteri (Figure S3) appears to be approaching a closed pan-genome model, with
newly sequenced strains contributing very small numbers of new genes to the pan-genome;
however we see an interesting community substructure within this species. Our current L.
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reuteri pan-genome analysis of seven isolates suggests four of the seven currently sequenced
isolates are very similar to one another, contributing zero to two new genes to the pan-genome.
Two further strains are also similar to one another, each contributing an intermediate number
of new genes (~15–30), whereas one outlier strain contributes a distinct set of genes (~330).
These findings are consistent with the comparison of average nucleotide identity with gene
content discussed below for this species. It will be interesting to see whether additional
sequencing of this species identifies other subgroups in addition to the three identified here, or
whether this sample set is in fact largely representative of the species.
Similar findings for B. longum (Figure S4) suggest that four of the five currently sequenced
genomes contribute approximately equally to the pan-genome (~50–150), with one outlier
strain (ATCC 15697) contributing a much higher number of novel genes (~640). These data
are consistent with differences in gene count across these genomes. Each of the five currently
sequenced genomes of E. faecalis (Figure S5) contributes approximately equivalent numbers
of new genes to the pan-genome. Our current datasets for these two species are still too small
to determine whether we can realistically achieve a closed pan-genome, with newly sequenced
isolates contributing on the order of 100 new genes each. It is unrealistic at this point to
extrapolate how many additional genomes would need to be sequenced to see whether the
number of new genes contributed by each new sequence continues to plateau around 100 new
genes or approaches zero.
S. aureus pan-genome plots (Figure S6), representing isolates collected from the skin,
urogenital tract and mucus membrane of mammals (human, bovine) are consistent with a closed
pan-genome model, as previously suggested (6), with an estimated core size of 2295 genes and
an estimated pan-genome size of ~3200 genes.
We performed a preliminary survey looking into the functions encoded by those genes unique
to new gene datasets, and not found in the core dataset, based on gene product annotation and
Enzyme Commission (EC) numbers, when available. It should be stressed that these genomes
underwent automated annotation only, with no manual curation, so any trends seen should be
considered putative only. Across all four species, the number of novel genes annotated only
as hypothetical or conserved domain of unknown function ranged from 66% to 73%,
comprising the bulk of the novel genes identified by the pan-genome analysis. Another
predominant trend seen were unique family members corresponding to non-novel functions,
e.g. functions also identified in the core dataset.
Potentially interesting categories of functions identified in novel gene sets unique to individual
strains include accessory proteins involved in activation of urease, a virulence factor found in
microorganisms associated with gastric ulceration, among other human health concerns(5)
phage morphogenesis and regulation proteins; and small numbers of unique enzymes involved
in metabolism of sugars and amino acids. Further work is needed to clean up annotations and
to provide more consistent EC number assignments in order to confirm and build upon trends
seen in this preliminary analysis. The HMP Data Analysis and Coordination Center (DACC)
is mandated with adding value and updating annotations, which will allow for expansion of
these analyses throughout this project.
Measuring diversity within genera
The genomic diversity among strains belonging to the same genus was explored by a measure
for the evolutionary relatedness and gene content similarity in a pair wise fashion (Figure 3).
The average nucleotide identity (ANI) is a measure for evolutionary relatedness based on
sequence similarity between the set of shared genes (8). The measure of gene content similarity
between two strains can provides a sense of functional or ecological relatedness, and one might
predict that strains with a lower gene content similarity are more likely to be found in different
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habitats. The three genera selected for this comparison all contain at least 16 strains and include
Lactobacillus (36 strains; Figure 3), Bifidobacterium (16 strains; Figure S7), and
Bacteroides (21 strains; Figure S8). Genomes contributed by the HMP as well as those available
in public databases were included in this analysis. High intra-species diversity was observed
within genera in addition to inter-species diversity. Within Lactobacillus, several species
showed significant diversity. For example, L. reuteri is represented by two main groups, one
set (bottom left blue oval in Fig. 3) contains 7 different strains. Among the strains within that
group, the %ANI and % gene content are above 98% and 90% respectively. In the second group
(upper right blue oval in Fig. 3), the % ANI ranges between 96% and 93% with a gene content
similarity lower than 78%. Previously, a value of 95%ANI was shown to correspond with the
recommended cut-off of 70 % DNA–DNA reassociation for species delineation (9). This
indicates that the L. reuteri strains obtained within the framework of the HMP significantly
increased the known genomic diversity of this named species, as was also demonstrated by the
pan-genome analysis. Other strains showing large intra-species diversity belong to L.
johnsonii and L. gasseri.
Among the strains of B. longum (Figure S7), four (two of which were contributed by the HMP)
have pair-wise %ANI values at the higher end of the spectrum, ranging between 96% and 98%,
but with relative low gene content similarity, i.e., below 82%, indicating a broad range in gene
complements. One additional existing strain (ATCC 15697) has a %ANI below 95% and a
gene content similarity below 65% and is therefore a clear evolutionary and ecological outlier.
The analysis of Bacteroides genomes has revealed several close common ancestries.
Bacteroides sp. D4 and 9_1_42FAA are closely related to Bacteroides dorei (ANI > 95%), but
still with a significant gene content difference, lower than 78% similarity. This suggests that
the Bacteroides group may possess many closely related, yet ecologically distinct lineages
Novel genes
The 547,968 predicted polypeptides corresponding to the entire annotated gene complement
of these strains (of which 516,631 (94%) were unique) were searched against the bacterial and
viral divisions of NCBI’s non-redundant protein database (nr) using WU-BLASTP as described
in the supporting information. Each polypeptide was also compared to a merged database of
TIGRFAM and Pfam HMMs using version 2a of the HMMER3 package. A set of candidate
“novel” polypeptides was defined by selecting those that had both (A) unmasked sequence
length > 100 amino acids and (B) no BLASTP match to any non-reference entry in the nr
subset. This analysis resulted in a set of 30,867 polypeptides, 5.6% of the total, of which 29,987
(~97%) were unique (10). Clustering this set with CD-HIT (11) resulted in 29,286 unique
polypeptides at 98% sequence identity (~5% reduction), 28,857 polypeptides at 95% (~7%
reduction), and 28,469 at 90% (~8% reduction). An alternate set of candidate novel
polypeptides was also defined by modifying condition (A) above to filter on the number of
bases not identified as low complexity sequences by SEG (12) (i.e., the sequence length after
removing all seg-masked bases). This alternate initial set contains 28,693 polypeptides.
The above criteria were chosen by inspecting histograms of novel versus non-novel polypeptide
counts at various E-value and sequence length thresholds and selecting cutoffs that seemed
likely to minimize the number of false positives while not excluding too many true positives.
The distribution of novel versus non-novel polypeptide counts overlaps at all E-value
thresholds, making it impossible to pick a cutoff that does not exclude any true positives.
Therefore a relatively high (100 aa) length threshold was selected in order to try to minimize
noise or false positives, at the possible cost of losing some real novel polypeptides.
With ~1,300 completely sequenced bacterial genomes in GenBank(13) the observation that
5% of the genes annotated in the HMP genomes satisfy criteria for novelty underscores the
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remarkable diversity of bacterial proteins. In order to assess whether there is enriched novelty
in the HMP-targeted genomes in relationship to previously sequenced prokaryotic genomes,
we randomly selected 178 previously sequenced draft genomes from GenBank and ran the
same analysis for comparison. This dataset resulted in 747,522 predicted polypeptides, of
which 568,426 were unique. Of these, 14,269 polypeptides met our criteria for novelty, 1.9%
of the total, of which 14,064 were unique, 2.5% of the unique total. Clustering resulted in a
2% reduction at 98% and a 3% reduction at 90%, indicating that this dataset does not contain
as many highly similar protein predictions as the HMP novel set. This would suggest that there
is enrichment in novelty in the HMP dataset of approximately 2:1 over the random dataset.
While the human microbiome is generally thought to be less complex than soils, and certain
other environmental microbiomes, it nevertheless clearly houses enormous microbial diversity
yet to be described.
Analysis of metagenomic shotgun data
Because the HMP reference genomes that were sequenced had been selected primarily because
they were isolates from human subjects, and had not been identified as strains seen in
metagenomics studies, it was not known how much these genomes would help identify
metagenomic sequences obtained from human microbial communities. The most useful
reference genomes should expand our ability to interpret metagenomic data. We also used the
stringent fragment recruitment technique (14) to compare metagenomic sequencing data to the
reference genomes in nucleotide space(15). The stringency of this approach generally limits
recruitment of metagenomic reads to organisms within the same genus but can resolve strain
specific differences.
Publicly available metagenomic datasets from two human gastrointestinal studies were used
in this analysis (16,17), along with 454 reads from a Washington University dataset (which
contributed the bulk of the 16.8 million reads that were tested). The reference genomes included
866 complete and 913 draft genomes available at NCBI including the HMP reference genomes
with sequence reads available at the time of analysis. In total 62 HMP genomes showed
significant levels of recruitment with 11.3 million metagenomic reads recruited (66% of all
reads). Of these, a significant 6.9 million reads (41%) recruited best to the HMP reference
genomes, based on the global percent identity (defined as the number of identities between
read and reference divided by the length of the read). A read is considered to be a best hit to
an HMP genome if the best global percent identity includes a match to an HMP genome. Many
of these reads would not have been recruited at all if not for the availability of the HMP
reference genomes: between 20% and 40% of the reads were recruited only because of the
presence of the HMP genomes.
These results show that a significant number of the genomes sequenced as part of the HMP
project are directly adding to our understanding the human microbiome. These results also
show that specific genomes are useful references across a wide range of individuals despite
the strain specific diversity noted above. Despite the large number of genomes available, a
significant amount of the metagenome (33%) is still not well represented by any reference
genome. It is likely that the 900 genomes target of the HMP will reduce this number of
unidentified reads further without redundancy in genome selection. It should be noted that this
analysis focused on the gastrointestinal tract and it is likely that additional genomes exist in
other body sites, and thus the composition of the 900 genomes should address these organisms.
Data release, future plans and conclusions
The Jumpstart Centers have made significant progress with respect to the generation of a set
of reference genomes that describe the human microbiome. We have made every effort to
ensure that all strains are available in public repositories, and to release these genomes and
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their associated data, assemblies and annotations in accordance with NIH policy (18). In
addition, all data and SOPs are available through the Data Analysis and Coordination Center
(DACC; (19)) where we welcome community input and feedback.
Human microbiome research groups from around the world have launched an International
Human Microbiome Consortium (IHMC), which together will sequence more than 1000
human microbial bacterial reference genomes. This includes the 900 reference strains that are
being sequenced by the HMP Jumpstart Centers, 100 genomes sequenced as part of the EU-
funded MetaHIT project(20), and additional genomes produced by international efforts. Other
strains are being sequenced as part of the DOE Genomic Encyclopedia of Bacteria and Archaea
(GEBA; (21,22)) project. All of these strains appear on the DACC.
Nevertheless, the human microbiome is much more complex than this set of genomes, and is
likely to exceed it by orders of magnitude. In addition to the significant number of cultured
strains, many unculturable strains remain to be defined, and significant intraspecies diversity
still needs to be described. Thus, this initial effort is only a beginning, is valuable, and not only
contributes to the catalog of reference strains but also builds infrastructure for strain selection
and acquisition, developing methods for sequencing unculturables, defining standards for the
various deliverables, providing online access to the large new data set, and for addressing many
other issues.
Of particular note is the development of standards that will be applied to the 900 genomes that
are being sequenced. This will provide a new and higher level of uniformity to microbial
genome data. The Jumpstart Consortium members are also in discussion with other consortia
interested in standards to extend this uniformity beyond the HMP.
While this report and the initial stage of the HMP focus on bacteria, this effort is currently
being expanded to produce reference genomes for eukaryotic microbes and viruses. These other
components of the human microbiome have not been forgotten, but the initial focus on bacteria
has allowed necessary infrastructure to be developed for the large task ahead. This can now be
readily deployed for other organisms. It is our ultimate goal to sample the human microbiome
as completely as possible.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Phylogenetic tree of 16S rDNA sequences
The tree was created using ~1500 16S rDNA representing single species. Organisms sequenced
as part of the HMP project are highlighted in blue. Additional coloring indicates separation by
phylum: yellow, Actinobacteria; dark green, Bacteroidetes; light green, Cyanobacteria; red,
Firmicutes; cyan, Fusobacteria; dark red Planctomycetes; grey, Proteobacteria; magenta,
Spirochaetes; light pink, TM7; tan, Tenericutes. The purpose of this analysis is not the details
of the branching structure (which include minor known artifacts), but the overall distribution
of the HMP strains (in blue) around the tree of life.
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Figure 2. Contig N50 comparison for twenty-six draft and improved genomes
High quality draft contig N50 bases are shown in magenta and improved high quality draft
sequences are shown in green. These data represent the variety of approaches from the four
data generation centers. The majority of shotgun data were produced on the Roche-454
platform, though some assemblies include paired Sanger reads to improve contiguity. All draft
assemblies are based on the Roche-Newbler assembler, though some of the improved
assemblies are based on PCAP (11) and the Celera assembler due to existing integration with
finishing and improvement pipelines. Additional variation comes from the improvement
approach. Directed Sanger reads from gap spanning PCR amplicons serves as the primary
approach while some assemblies have been subjected only to manipulation of the shotgun data,
making unrealized joins, removing poor quality data and placing unincorporated shotgun reads.
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Figure 3. Inter-strain diversity among Lactobacillus genomes
Each point represents a whole-genome comparison between two Lactobacillus genomes and
shows the percentage average nucleotide identity (ANI) on the x-axis as a measure of
evolutionary distance, plotted against the percentage of gene content similarity on the y-axis.
Only comparisons with ANI values above 85% are shown. The vertical line at 95% corresponds
to a recommended cut-off of 70% DNA–DNA reassociation for species delineation. Different
intra- and inter-species comparisons are color-coded, with full or open circles respectively, and
labeled with given taxonomical name in corresponding color. Colored ovals assist in
identifying related data points belonging to a single named species.
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